Edward A. Neuwelt, M.D.
- click here
After receiving his medical degree from the University of Colorado Medical School, Denver, in 1972, Dr. Neuwelt completed his Neurosurgery residency at the University of Texas Southwest Medical School in Dallas. He continued his medical education by completing his Neurosurgery fellowship at the Queen Square Hospital in London, England. His special interests include neurooncology and microsurgery. Dr. Neuwelt currently serves as the director of the Blood Brain Barrier Program, and the administrator of the Head and Spinal Cord Injury Prevention Program.
"Delivery of chemotherapeutics across the blood-brain barrier: Challenges and advances,"
"Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question,"
"N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models,"
"Preclinical high-dose acetaminophen with N-acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumors.,"
"A 67-year-old woman receiving tumor necrosis factor Î± inhibitor therapy presenting with neurologic dysfunction,"